Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Buhl

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Therapeutic Advances in Respiratory Disease|October 1, 2024
Long-acting muscarinic antagonist and long-acting β<sub>2</sub>-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative reviewRoland Buhl, Marc Miravitlles, Antonio Anzueto, et al.
Respiratory Medicine|September 29, 2018
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β<sub>2</sub>-agonists for adults with asthmaRoland Buhl, J Mark FitzGerald, William W Busse
Journal of Immunoassay & Immunochemistry|January 18, 2013
The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumabPavel Strohner, Stephanie Korn, Roland Buhl, et al.
MMW Fortschritte Der Medizin|December 30, 2009
[Modern management of asthma]Ina Haasler, Stephanie Korn, Roland Buhl, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 29, 2012
Guideline-based survey of outpatient COPD management by pulmonary specialists in GermanyThomas Glaab, Claus Vogelmeier, Andreas Hellmann, et al.
The European Respiratory Journal|September 8, 2018
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literatureTimm Volmer, Timo Effenberger, Christoph Trautner, et al.
International Archives of Allergy and Immunology|August 3, 2004
Sputum levels of reduced glutathione increase 24 hours after allergen challenge in isolated early, but not dual asthmatic respondersJutta Beier, Kai Michael Beeh, David Semmler, et al.
Chest|October 16, 2004
Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPDKai Michael Beeh, Jutta Beier, Nicole Koppenhoefer, et al.
The Journal of Laboratory and Clinical Medicine|July 15, 2004
Induced sputum methodology: Validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individualsJutta Beier, Kai-Michael Beeh, Oliver Kornmann, et al.
Respiratory Medicine|December 1, 2014
Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trialsJadwiga A Wedzicha, Roland Buhl, David Lawrence, et al.
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Therapeutic Advances in Respiratory Disease|October 1, 2024
Long-acting muscarinic antagonist and long-acting β<sub>2</sub>-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative reviewRoland Buhl, Marc Miravitlles, Antonio Anzueto, et al.
Respiratory Medicine|September 29, 2018
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β<sub>2</sub>-agonists for adults with asthmaRoland Buhl, J Mark FitzGerald, William W Busse
Journal of Immunoassay & Immunochemistry|January 18, 2013
The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumabPavel Strohner, Stephanie Korn, Roland Buhl, et al.
MMW Fortschritte Der Medizin|December 30, 2009
[Modern management of asthma]Ina Haasler, Stephanie Korn, Roland Buhl, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 29, 2012
Guideline-based survey of outpatient COPD management by pulmonary specialists in GermanyThomas Glaab, Claus Vogelmeier, Andreas Hellmann, et al.
The European Respiratory Journal|September 8, 2018
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literatureTimm Volmer, Timo Effenberger, Christoph Trautner, et al.
International Archives of Allergy and Immunology|August 3, 2004
Sputum levels of reduced glutathione increase 24 hours after allergen challenge in isolated early, but not dual asthmatic respondersJutta Beier, Kai Michael Beeh, David Semmler, et al.
Chest|October 16, 2004
Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPDKai Michael Beeh, Jutta Beier, Nicole Koppenhoefer, et al.
The Journal of Laboratory and Clinical Medicine|July 15, 2004
Induced sputum methodology: Validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individualsJutta Beier, Kai-Michael Beeh, Oliver Kornmann, et al.
Respiratory Medicine|December 1, 2014
Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trialsJadwiga A Wedzicha, Roland Buhl, David Lawrence, et al.
Pageof 24